What is Texray?
Texray has pioneered the development of the world's first radiation protection textile, engineered to significantly enhance the safety of medical professionals during fluoroscopy-guided interventions. Their proprietary technology is designed to mitigate scatter radiation, with documented efficacy in achieving up to 97% dose reduction. The company's product line, including MasterPeace, HeadPeace, and MindPeace, offers advanced solutions for healthcare providers globally, distributed through a network of trusted partners.
How much funding has Texray raised?
Texray has raised a total of $4.3M across 1 funding round:
Other Financing Round
$4.3M
Other Financing Round (2023): $4.3M with participation from Industrifonden
Key Investors in Texray
Industrifonden
Industrifonden is a Swedish venture capital fund that invests in unique, scalable innovations aimed at improving society through breakthrough technologies and science. The fund focuses on areas such as deep tech, life sciences, and transformative tech, partnering with passionate founders to bring their ideas to life.
What's next for Texray?
The recent major strategic investment positions Texray for accelerated growth and market penetration. This financing is expected to fuel further research and development, expand manufacturing capabilities, and broaden the company's global distribution network. With a clear focus on improving safety standards in medical procedures, Texray is poised to solidify its leadership in the radiation protection market, leveraging this capital to scale its operations and reach more healthcare professionals worldwide.
See full Texray company page
